Retrospective single-center historical comparative study between proGAV and proGAV2.0 for surgical revision and implant duration.
E BrunnerA SchaumannV PennacchiettiM SchulzUlrich Wilhelm ThomalePublished in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2022)
The shunt and valve revision-free survival rates were found to be similar among the groups during 30 month follow-up. In patients who received "valve only" revisions and a subsequent explanation, the implant duration was significantly longer in the proGAV. Although the amount of patients with valve-only-revisions are small compared to the entire cohort certain patients seem to be at higher risk for repeated valve revisions.
Keyphrases
- aortic valve
- mitral valve
- aortic stenosis
- ejection fraction
- free survival
- total knee arthroplasty
- end stage renal disease
- transcatheter aortic valve replacement
- newly diagnosed
- total hip arthroplasty
- chronic kidney disease
- left ventricular
- coronary artery disease
- pulmonary hypertension
- patient reported outcomes
- patient reported
- breast cancer risk